Fundz

Who to call at Aarvik Therapeutics, and when

Fundz watches for the moments Aarvik Therapeutics starts buying, and tells you who to reach.

  • An alert the day Aarvik Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aarvik Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aarvik Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Aarvik Therapeutics announces collaboration option exercise by ArriVent BioPharma

Aug 15, 2024

Contract Type

partnership

HaywardBiotechnologyHealthcareHealth CareTherapeuticsresearch

Description

Aarvik Therapeutics is pleased to announce that its collaboration partner ArriVent BioPharma, Inc. has exercised the option to exclusively license the collaboration program. As part of the research collaboration agreement, Aarvik has been responsible for discovery and preclinical development of a novel ADC molecule, while ArriVent will be responsible for clinical development and commercialization.

Quick answer

Aarvik Therapeutics announces collaboration option exercise by ArriVent BioPharma (August 15, 2024). Aarvik Therapeutics is based in Hayward, California, United States.

What agreement did Aarvik Therapeutics announce on August 15, 2024?
Aarvik Therapeutics is pleased to announce that its collaboration partner ArriVent BioPharma, Inc. has exercised the option to exclusively license the collaboration program. As part of the research collaboration agreement, Aarvik has been responsible for discovery and preclinical development of a novel ADC molecule, while ArriVent will be responsible for clinical development and commercialization.
What does Aarvik Therapeutics do?
Aarvik Therapeutics is pursuing exciting, novel molecules with an improved therapeutic index for several oncology targets by combining a novel modular antibody platform with multiple target mechanisms.
Where is Aarvik Therapeutics based?
Aarvik Therapeutics is based in Hayward, California, United States.

Source: Fundz verified event record.

Company Information

Company

Aarvik Therapeutics

Location

Hayward, California, United States

About

Aarvik Therapeutics is pursuing exciting, novel molecules with an improved therapeutic index for several oncology targets by combining a novel modular antibody platform with multiple target mechanisms.

Related People

Jagath
Senior decision-maker at this company
••••••••@••••••••

See Jagath's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aarvik Therapeutics's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Aarvik Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.